Associated Papers
Adalimumab-responsive Monogenic Inflammatory Bowel Disease With Pseudopolyposis Characteristic of TGFBR2 Variant in Loeys-Dietz Syndrome.
Sado T et al.
Den Open, 2026
Real-World Efficacy, Safety, and Drug Retention of Anakinra and Canakinumab in Pediatric Colchicine-Resistant Familial Mediterranean Fever: Insights from a Single-Center Cohort.
Çağlayan Ş et al.
Modern Rheumatology, 2026
Machine learning algorithms for predicting colchicine resistance in familial Mediterranean fever.
Öztürk A et al.
Rheumatology (oxford, England), 2026
Familial Mediterranean Fever Presenting with Recurrent Abdominal Pain without Periodic Fever following COVID-19: A Case Report.
Ueno N et al.
Internal Medicine (tokyo, Japan), 2026
Clinical features of patients with familial Mediterranean fever over 50 years of age: a single-center experience.
Baspinar SN et al.
Internal and Emergency Medicine, 2026
Evaluation of pediatric FMF patients with biallelic pathogenic exon 10 variants: focus on chest pain.
Tunce E et al.
European Journal of Pediatrics, 2026
Genetic, and clinical features in Italian and lebanese subjects with familial mediterranean fever (FMF).
Jaber N et al.
European Journal of Internal Medicine, 2026
Increased risk of psoriatic arthritis in patients with familial Mediterranean fever: a population-based cohort study.
Haddad A et al.
Rheumatology (oxford, England), 2026
Inflammatory ankle MRI findings in pediatric and young adult patients with familial Mediterranean fever: a comparison with juvenile idiopathic arthritis and chronic nonbacterial osteomyelitis.
Kraus M et al.
Skeletal Radiology, 2026
Targeting cytokine pathways: the role of biologics in autoinflammatory disorders.
Koga T
Expert Review of Clinical Immunology, 2026
Anti-citrullinated Protein Antibody-positive Arthralgia Associated with an L110P-E148Q Double Heterozygote: A Case-based Review.
Itoh K et al.
Internal Medicine (tokyo, Japan), 2026
Maternal and fetal risks in familial mediterranean fever: focus on adverse pregnancy outcomes.
Çetin Ç et al.
Clinical Rheumatology, 2026
Colchicine discontinuation in familial Mediterranean fever: short-term outcomes by pre-discontinuation attack frequency.
Aktas B et al.
Clinical Rheumatology, 2026
Long-Term outcomes of children diagnosed with indeterminate colitis.
Cetinoglu S et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-arab Association of Gastroenterology, 2026
The clinical significance of the Mediterranean fever gene MEFV variants in Castleman disease.
Du Y et al.
Communications Medicine, 2026
Cachexia as an unusual presentation of familial Mediterranean fever: A case report.
Sira AM et al.
World Journal of Clinical Cases, 2026
The Relationship Between Gene Subtypes, Symptoms, and Cardiac Function in Patients with Familial Mediterranean Fever.
Kızılkaya B et al.
Journal of Clinical Medicine, 2026
Clinical and genomic features of Iranian patients with very early onset IBD.
Haghipanah M et al.
Pediatric Research, 2026
Monogenic disorders of immunity: Common variants are not so rare.
Béziat V et al.
Cell Genomics, 2026
Is the decision maker a key determinant of colchicine withdrawal success in paediatric heterozygous familial Mediterranean fever patients?
Özomay Baykal G et al.
Scandinavian Journal of Rheumatology, 2026
Accurate Diagnosis of Familial Mediterranean Fever Improved Quality of Life for a Patient and Her Family: A Case Report.
Kurihara M et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi, 2026
Colchicine prophylaxis in pediatric PFAPA: a systematic review.
Dipasquale RF et al.
European Journal of Pediatrics, 2026
Familial Mediterranean Fever: A Comprehensive Review of Pathogenesis, Genetics, and Epigenetic Regulation.
Ugurlu S et al.
Balkan Medical Journal, 2026
The Quality of Life in Patients with Familial Mediterranean Fever and Their Parents Perception.
Ensari E et al.
Klinische Padiatrie, 2026
Co-Existence of IL6ST and MEFV Pathogenic Variant in a Patient With Hyper-IgE Syndrome.
Kose H et al.
Immunology, 2026
Impact of MEFV gene variants on clinical presentation in Familial Mediterranean Fever: A focus on Exon 2 mutations.
Kulaksiz B et al.
Reumatologia Clinica, 2026
Impact of Mediterranean Fever Gene Mutations on Clinical Characteristics in Patients With Inflammatory Bowel Disease.
Nakamura T et al.
Gastro Hep Advances, 2026
Evaluation of the Effect of IL-1 Antagonists on Pituitary Function.
Aktas Koc F et al.
International Journal of Endocrinology, 2026
Growth and pubertal development in children with familial Mediterranean fever under colchicine therapy.
Bayrak Demirel O et al.
European Journal of Pediatrics, 2025
Age estimation of single nucleotide polymorphisms associated with autoinflammatory diseases in anatolia: insights from ancient and modern DNA.
Karadavut D et al.
Human Genetics, 2025
Nephrotic syndrome genomic discovery in the Mass General Brigham Biobank identifies monoallelic MEFV variants as a risk factor for focal segmental glomerulosclerosis.
Wongboonsin J et al.
Kidney International, 2025
Abdominal Pain Attacks and Angioedema in a Patient With a Homozygous MEFV Mutation: Concurrent FXII Hereditary Angioedema.
Bulut G et al.
Journal of Investigational Allergology & Clinical Immunology, 2025
Serum resistin levels in pediatric familial Mediterranean fever: Potential biomarker for inflammatory activity.
Morad LM et al.
World Journal of Clinical Pediatrics, 2025
Overlap of familial Mediterranean fever and APLAID treated with anakinra: a case-based review.
Akoglu G et al.
Clinical Rheumatology, 2025
Genetics of IgA Vasculitis: What We Know and Where We Are Going.
Roganović J et al.
Acta Medica Academica, 2025
Association of Mediterranean diet adherence with familial Mediterranean fever severity in a Lebanese cohort.
Hammoud R et al.
Pediatric Rheumatology Online Journal, 2025
[An unusual cause for kidney transplantation].
Kremer P et al.
Innere Medizin (heidelberg, Germany), 2025
The Landscape of Genetic Variation and Disease Risk in Romania: A Single-Center Study of Autosomal Recessive Carrier Frequencies and Molecular Variants.
Gug M et al.
International Journal of Molecular Sciences, 2025
Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study.
Cam V et al.
Rheumatology (oxford, England), 2025
Impact of Familial Mediterranean Fever on Choroidal Tissue: A Study of Choroidal Thickness and Vascularity in Pediatric Patients.
Gürbostan Soysal G et al.
Ocular Immunology and Inflammation, 2025
Vascular characteristics of pediatric patients with familial Mediterranean fever: a study of optical coherence tomography angiography findings.
Soysal GG et al.
Japanese Journal of Ophthalmology, 2025
[Use of IL-1 inhibitors in the treatment of familial Mediterranean fever in pediatric rheumatology].
Hillekamp C et al.
Zeitschrift Fur Rheumatologie, 2025
Transcriptome analysis of unmedicated heterozygous familial Mediterranean fever patients reveals a type I interferon signature driving increasing Pyrin expression.
Sag E et al.
Annals of the Rheumatic Diseases, 2025
Familial Mediterranean Fever With Compound Heterozygosity for the Pyrin Variant L110P-E148Q: A Case Report.
Fukuda S et al.
Cureus, 2025
Effect of MEFV mutations and HLA-B27 on clinical findings of familial Mediterranean fever and spondyloarthritis.
Yuce Inel T et al.
Medicine, 2025
Retinal clues to subclinical inflammation in familial Mediterranean fever.
Başaran Ö et al.
Pediatric Research, 2025
Liver function changes in pediatric FMF: exploring disease dynamics and therapy impacts.
Başer Taşkın B et al.
European Journal of Pediatrics, 2025